Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts
Author:
Funder
Taiwan Ministry of Science and Technology
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference52 articles.
1. DAPA-HF Trial Committees and Investigators. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction;McMurray;N. Engl. J. Med.,2019
2. Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart;Van Steenbergen;Sci. Rep.,2017
3. Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts;Lee;Free Radic. Biol. Med.,2017
4. Expression of SGLT1 in human hearts and impairment of cardiac glucose uptake by phlorizin during ischemia–reperfusion injury in mice;Kashiwagi;PLoS One,2015
5. Z. Li, V. Agrawal, M. Ramratnam, R.K. Sharma, S. D'Auria, A. Sincoular, et al, Cardiac sodium-dependent glucose cotransporter 1 is a novel mediator of ischaemia/reperfusion injury, Cardiovasc. Res. 115 (2019) 1646-1658.
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: Lessons from preclinical studies;Chemico-Biological Interactions;2024-11
2. The Effect of Dapagliflozin on Heart Function in Animal Models of Cardiac Ischemia, A Systematic Review and Meta-analysis;Current Reviews in Clinical and Experimental Pharmacology;2024-07-24
3. The potential anti-arrhythmic effect of SGLT2 inhibitors;Cardiovascular Diabetology;2024-07-15
4. Empagliflozin rescues pro-arrhythmic and Ca2+ homeostatic effects of transverse aortic constriction in intact murine hearts;Scientific Reports;2024-07-08
5. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review;Biomedicine & Pharmacotherapy;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3